Alessandro Liberati

1954 - 2012

country of citizenship: Italy

languages spoken, written or signed: Italian

Alessandro Liberati (Genoa, Italy, 27 April 1954 – Bologna, Italy, 1 January 2012) was an Italian healthcare researcher and clinical epidemiologist, and founder of the Italian Cochrane Centre. Source: Wikipedia (en)

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 72

Date

Title

Authors

2015

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

Alessandro Liberati, David Moher, Davina Ghersi, Larissa Shamseer, Mark Petticrew, Paul G Shekelle, Mike Clarke, Matthias Egger
2013-01-09

Developing and Evaluating Communication Strategies to Support Informed Decisions and Practice Based on Evidence (DECIDE): protocol and preliminary results

Per Olav Vandvik, Linn Brandt, Pablo Alonso-Coello, Shaun Treweek, Signe Flottorp, Marina Davoli, Patrick Bossuyt, Alessandro Liberati, Andrew D. Oxman, Jan Brozek, Holger Schünemann, Govin Permanand, Sarah E Rosenbaum
2012-10-03

Timing matters in hip fracture surgery: patients operated within 48 hours have better outcomes. A meta-analysis and meta-regression of over 190,000 patients

Gianni Virgili, Cristian Ricci, Lorenzo Moja, Georgia Salanti, Giuseppe Banfi, Alessandro Liberati
2012-10-03

Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave dreams study (brain venous drainage exploited against multiple sclerosis): study protocol for a randomized controlled trial

Roberto D'Amico, Luca Massacesi, Luigi Tesio, Massimo Del Sette, Antonio Bertolotto, Alessandro Liberati
2012-01-26

Patient empowerment as a component of health system reforms: rights, benefits and vested interests

Cinzia Colombo, Paola Mosconi, Lorenzo Moja, Alessandro Liberati
2012-08-03

GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence

Joanne Lord, Marina Davoli, Laura Amato, Gordon Guyatt, Alessandro Liberati, Andrew D. Oxman, Mark Helfand, Holger Schünemann
2012-09-02

Multiple systematic reviews: methods for assessing discordances of results

Roberto D'Amico, Gianni Virgili, Ersilia Lucenteforte, Elena Parmelli, Lorenzo Moja, Alessandro Liberati
2011-06-24

Conceptual frameworks and empirical approaches used to assess the impact of health research: an overview of reviews

Alessandro Liberati
2011-09-23

Speed of updating online evidence based point of care summaries: prospective cohort analysis

Lorenzo Moja, Alessandro Liberati
2010-07-06

Updating clinical recommendations for breast, colorectal and lung cancer treatments: an opportunity to improve methodology and clinical relevance

Elena Parmelli, Giovannino Ciccone, Alessandro Liberati
2010

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Douglas G. Altman, David Moher, Jennifer Tetzlaff, Alessandro Liberati
2010-07-07

A review of online evidence-based practice point-of-care information summary providers

Lorenzo Moja, Alessandro Liberati
2010-09-09

Review of Online Evidence-based Practice Point-of-Care Information Summary Providers: Authors’ Reply to the Response by the Publisher of DynaMed

Alessandro Liberati
2010-10

Comment to “Why are Cochrane hepato-biliary reviews undervalued by physicians as an aid for clinical decision making?”

Marina Davoli, Alessandro Liberati
2009-07-21

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Alessandro Liberati, John Ioannidis, Peter C. Gøtzsche, David Moher, Douglas G. Altman, Jos Kleijnen, Jennifer Tetzlaff, Mike Clarke, Philip James Devereaux, Cynthia Mulrow
2009-07-21

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Alessandro Liberati, David Moher, Douglas G. Altman, Jennifer Tetzlaff
2009-10-07

Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care

Roberto D'Amico, Luca Brazzi, Alessandro Liberati
2009-10

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Douglas G. Altman, David Moher, Jennifer Tetzlaff, Alessandro Liberati
2009-07-21

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

Peter C. Gøtzsche, Douglas G. Altman, David Moher, John Ioannidis, Jos Kleijnen, Jennifer Tetzlaff, Alessandro Liberati, Mike Clarke, Philip James Devereaux, Cynthia Mulrow
2009-08-18

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Douglas G. Altman, David Moher, Jennifer Tetzlaff, Alessandro Liberati, Matthias Egger
2009-10

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Peter C. Gøtzsche, John Ioannidis, Alessandro Liberati, Douglas G. Altman, David Moher, Jos Kleijnen, Jennifer Tetzlaff, Mike Clarke, Philip James Devereaux, Cynthia Mulrow
2009-07-21

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Douglas G. Altman, David Moher, Jennifer Tetzlaff, Alessandro Liberati
2009-08-18

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

David Moher, Peter C. Gøtzsche, John Ioannidis, Douglas G. Altman, Jennifer Tetzlaff, Alessandro Liberati, Mike Clarke, Jos Kleijnen, Philip James Devereaux, Cynthia Mulrow
2009-05-29

Informing women about hormone replacement therapy: the consensus conference statement

Cinzia Colombo, Paola Mosconi, Alessandro Liberati, Serena Donati
2009-07-22

Compliance of clinical trial registries with the World Health Organization minimum data set: a survey

David Moher, Jimmy Volmink, Ida Sim, Lorenzo Moja, Jeremy Grimshaw, Alessandro Liberati, Kay Dickersin
2009-09-01

Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Douglas G. Altman, David Moher, Jennifer Tetzlaff, PRISMA Group, Alessandro Liberati
2009-12-01

Measuring the impact of evidence: the Cochrane systematic review of organised stroke care

Alessandro Liberati
2009-07-21

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

Douglas G. Altman, David Moher, Jennifer Tetzlaff, PRISMA Group, Alessandro Liberati
2008-05-01

Going from evidence to recommendations.

Gordon Guyatt, Alessandro Liberati, Andrew D. Oxman, Gunn Elisabeth Vist, Holger Schünemann
2008-05-01

Incorporating considerations of resources use into grading recommendations.

Gordon Guyatt, Alessandro Liberati, Andrew D. Oxman, Gunn Elisabeth Vist, Mark Helfand, Holger Schünemann
2008-09-01

When drug companies select what they want to publish patients are denied relevant therapeutic information

Alessandro Liberati
2008-03-04

Rimonabant for overweight and "metabolic syndrome": the attempt to supersize disease and risk by pharmaceutical marketing.

Lorenzo Moja, Alessandro Liberati

Human - wd:Q3610088

Welcome to Inventaire

the library of your friends and communities

learn more